Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.24 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1664
    +0.0012 (+0.10%)
     

  • GBP/USD

    1.2573
    +0.0027 (+0.21%)
     

  • Bitcoin GBP

    50,556.33
    -648.67 (-1.27%)
     

  • CMC Crypto 200

    1,366.16
    +53.54 (+4.08%)
     

  • S&P 500

    5,159.15
    +31.36 (+0.61%)
     

  • DOW

    38,735.83
    +60.15 (+0.16%)
     

  • CRUDE OIL

    78.65
    +0.54 (+0.69%)
     

  • GOLD FUTURES

    2,332.90
    +24.30 (+1.05%)
     

  • NIKKEI 225

    38,236.07
    -38.03 (-0.10%)
     

  • HANG SENG

    18,578.30
    +102.38 (+0.55%)
     

  • DAX

    18,175.21
    +173.61 (+0.96%)
     

  • CAC 40

    7,996.64
    +39.07 (+0.49%)
     

Microsoft nominates GSK CEO Walmsley to board

Reuters
GlaxoSmithKline CEO, Emma Walmsley, arrives for a meeting in Downing Street in central London

(Reuters) - Microsoft Corp said on Thursday it has nominated GlaxoSmithKline Plc Chief Executive Officer Emma Walmsley to its board of directors.

The software company said former chairman of the board of management at BMW AG, Helmut Panke, will not seek a re-election to the board after his current term expires.

Charles Noski, former vice chairman of AT&T Inc and Bank of America Corp, is also leaving the board.

The company's annual shareholder meeting is due on Dec.4.

Shares of the company were up 1.84% in after-market trading after rising to a record high during the regular trading hours after it announced a $40 billion (31.90 billion pounds) share buyback plan.

(Reporting by Neha Malara in Bengaluru; Editing by Arun Koyyur)